Laurie J. Olson - 15 Feb 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
-$25,140
Form type
4
Filing time
17 Feb 2022, 16:16:09 UTC
Previous filing
05 Jan 2022
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $84,860 +1,000 $84.86 1,000 15 Feb 2022 Direct
transaction KRTX Common Stock Sale $110,000 -1,000 -100% $110.00 0 15 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1,000 -5% $0.000000 19,000 15 Feb 2022 Common Stock 1,000 $84.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.